The Future of Immune Checkpoint Inhibition in Gastric and Esophageal Cancers

February 2, 2017
Geoffrey Y. Ku, MD

Geoffrey Y. Ku, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses the future of immune checkpoint inhibition in gastric and esophageal cancers.